PMC Links for Gene (Select 2064) - PMC

Links from Gene

Items: 1 to 20 of 1346

<< First< Prev

Page of 68

Next >Last >>

Select item 109977621.

Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer

Yoo-Na Kim, Yun Soo Chung, Eunhyang Park, Seung Tae Lee, Jung-Yun Lee

Sci Rep. 2024; 14: 7992. Published online 2024 Apr 5. doi: 10.1038/s41598-024-57515-y

PMCID:: PMC10997762

Article PDF–2.2M

Select item 109872952.

Site-specific glycosylation analysis of epidermal growth factor receptor 2 (ErbB2): exploring structure and function toward therapeutic targeting

Naoki Fujitani, Yasuaki Uehara, Shigeru Ariki, Ukichiro Hashimoto, Jo Mukai, Yoshihiro Hasegawa, Motoko Takahashi

Glycobiology. 2024 Mar; 34(3): cwad100. Published online 2023 Dec 18. doi: 10.1093/glycob/cwad100

Correction in:: Glycobiology. 2024 May; 34(5): cwae018.

PMCID:: PMC10987295

Article PDF–3.5M

Select item 108609463.

HER2-positive is an independent indicator for predicting pathological complete response to neoadjuvant therapy and Ki67-changed after neoadjuvant chemotherapy predicts favorable prognosis in Chinese women with locally advanced breast cancer

Yutong Fang, Qunchen Zhang, Yuan Wu, Jundong Wu

Medicine (Baltimore) 2024 Feb 9; 103(6): e37170. Published online 2024 Feb 9. doi: 10.1097/MD.0000000000037170

PMCID:: PMC10860946

Article PDF–1.7M

Select item 106045474.

Outcomes of advanced gastroesophageal cancer patients with equivocal HER2 expression with or without ERBB2 gene amplification

Ahmed Abdelhakeem, Xuemei Wang, Jane E. Rogers, Allison Trail, Meina Zhao, Mariela Blum-Murphy, J. S. Estrella, Jaffer A. Ajani

Oncology. Author manuscript; available in PMC 2023 Oct 27.

Published in final edited form as: Oncology. 2020; 98(12): 884–888. Published online 2020 Sep 30. doi: 10.1159/000509148

PMCID:: PMC10604547

Article PDF–262K

Select item 105055935.

Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients

Zhaoxu Chen, Huiqing Jia, Huina Zhang, Lifang Chen, Peng Zhao, Jing Zhao, Guangming Fu, Xiaoming Xing, Yujun Li, Chengqin Wang

Breast Cancer Res Treat. 2023; 202(2): 313–323. Published online 2023 Aug 28. doi: 10.1007/s10549-023-07079-8

PMCID:: PMC10505593

Article PDF–835K

Select item 102980706.

Upregulated Expression of ERBB2/HER2 in Multiple Myeloma as a Predictor of Poor Survival Outcomes

Fatih M. Uckun, Sanjive Qazi

Int J Mol Sci. 2023 Jun; 24(12): 9943. Published online 2023 Jun 9. doi: 10.3390/ijms24129943

PMCID:: PMC10298070

Article PDF–3.2M

Select item 101794627.

HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?

Marina Popović, Tajana Silovski, Marija Križić, Natalija Dedić Plavetić

Int J Mol Sci. 2023 May; 24(9): 8206. Published online 2023 May 4. doi: 10.3390/ijms24098206

PMCID:: PMC10179462

Article PDF–668K

Select item 101017918.

Real World Characteristics and Clinical Outcomes of HER2-Mutant Non–Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing

Beung-Chul Ahn, Ye-Jeong Han, Hye Ryun Kim, Min Hee Hong, Byoung Chul Cho, Sun Min Lim

Cancer Res Treat. 2023 Apr; 55(2): 488–497. Published online 2022 Nov 9. doi: 10.4143/crt.2022.359

PMCID:: PMC10101791

Article PDF–1.2M

Select item 100241229.

Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group

S.P. Gampenrieder, V. Dezentjé, M. Lambertini, A. de Nonneville, M. Marhold, F. Le Du, A. Cortés Salgado, D. Alpuim Costa, M. Vaz Batista, N. Chic Ruché, C. Tinchon, A. Petzer, E. Blondeaux, L. Del Mastro, G. Targato, F. Bertucci, A. Gonçalves, F. Viret, R. Bartsch, C. Mannsbart, A. Deleuze, L. Robert, C. Saavedra Serrano, M. Gion Cortés, M. Sampaio-Alves, M. Vitorino, L. Pecen, C. Singer, N. Harbeck, G. Rinnerthaler, R. Greil, AGMT Study Group

ESMO Open. 2023 Feb; 8(1): 100747. Published online 2022 Dec 21. doi: 10.1016/j.esmoop.2022.100747

PMCID:: PMC10024122

Article PDF–459K

Select item 999008010.

Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas

Dara S. Ross, Kelly A. Devereaux, Cao Jin, David YunTe Lin, Yanming Zhang, Antonio Marra, Vicky Makker, Britta Weigelt, Lora H. Ellenson, M. Herman Chui

Mod Pathol. Author manuscript; available in PMC 2023 Mar 7.

Published in final edited form as: Mod Pathol. 2022 Jul; 35(7): 962–971. Published online 2021 Dec 31. doi: 10.1038/s41379-021-00997-2

PMCID:: PMC9990080

Article PDF–2.4M

Select item 996268811.

HER2 Expression in Bladder Cancer: A Focused View on Its Diagnostic, Prognostic, and Predictive Role

Francesca Sanguedolce, Magda Zanelli, Andrea Palicelli, Alessandra Bisagni, Maurizio Zizzo, Stefano Ascani, Maria Carmela Pedicillo, Angelo Cormio, Ugo Giovanni Falagario, Giuseppe Carrieri, Luigi Cormio

Int J Mol Sci. 2023 Feb; 24(4): 3720. Published online 2023 Feb 13. doi: 10.3390/ijms24043720

PMCID:: PMC9962688

Article PDF–1.2M

Select item 987553312.

Radiogenomic analysis of prediction HER2 status in breast cancer by linking ultrasound radiomic feature module with biological functions

Hao Cui, Yue Sun, Dantong Zhao, Xudong Zhang, Hanqing Kong, Nana Hu, Panting Wang, Xiaoxuan Zuo, Wei Fan, Yuan Yao, Baiyang Fu, Jiawei Tian, Meixin Wu, Yue Gao, Shangwei Ning, Lei Zhang

J Transl Med. 2023; 21: 44. Published online 2023 Jan 24. doi: 10.1186/s12967-022-03840-7

PMCID:: PMC9875533

Article PDF–10M

Select item 979799913.

Characteristics of the immunogenicity and tumor immune microenvironment in HER2-amplified lung adenocarcinoma

Qinyang Wang, Ziyang Mao, Wenyuan Li, Shumei Wang, Lei Wang, Lin Chen, Zhe Yang, Xiaolan Fu, Panpan Jiang, Yixue Bai, Longwen Xu, Shirong Zhang, Yuzhu Hou, Xiaohui Jia, Lili Jiang, Mengjie Liu, Guanjun Zhang, Yina Jiang, Hui Guo

Front Immunol. 2022; 13: 1042072. Published online 2022 Dec 15. doi: 10.3389/fimmu.2022.1042072

PMCID:: PMC9797999

Article PDF–8.7M

Select item 971579814.

ERBB2 exon 20 insertions are rare in Brazilian non‐small cell lung cancer

Rodrigo de Oliveira Cavagna, Beatriz Garbe Zaniolo, Flávia Escremim de Paula, Gustavo Noriz Berardinelli, Iara Santana, Eduardo Caetano Albino da Silva, Josiane Mourão Dias, Alexandre Arthur Jacinto, Rachid Eduardo Noleto da Nóbrega Oliveira, Pedro de Marchi, Letícia Ferro Leal, Rui Manuel Reis

Thorac Cancer. 2022 Dec; 13(23): 3402–3407. Published online 2022 Oct 17. doi: 10.1111/1759-7714.14605

PMCID:: PMC9715798

Article PDF–812K

Select item 947877615.

Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France

Ombline de Calbiac, Amélie Lusque, Audrey Mailliez, Thomas Bachelot, Lionel Uwer, Marie-Ange Mouret-Reynier, George Emile, Christelle Jouannaud, Anthony Gonçalves, Anne Patsouris, Véronique Diéras, Marianne Leheurteur, Thierry Petit, Paul Cottu, Jean-Marc Ferrero, Véronique D'Hondt, Isabelle Desmoulins, Joana Mourato-Ribeiro, Anne-Laure Martin, Jean-Sébastien Frenel

JAMA Netw Open. 2022 Sep; 5(9): e2231170. Published online 2022 Sep 15. doi: 10.1001/jamanetworkopen.2022.31170

PMCID:: PMC9478776

Article

Select item 945516116.

HER2 c-Terminal Fragments Are Expressed via Internal Translation of the HER2 mRNA

Jack D. Godfrey, Daniel Hejazi, Xiaofei Du, Cenfu Wei, Eshaan Rao, Christopher M. Gomez

Int J Mol Sci. 2022 Sep; 23(17): 9549. Published online 2022 Aug 23. doi: 10.3390/ijms23179549

PMCID:: PMC9455161

Article PDF–947K

Select item 942538817.

The role of ERBB2 gene polymorphisms in leprosy susceptibility

Jamile Leão Rêgo, Joyce Moura Oliveira, Nadja de Lima Santana, Paulo Roberto Lima Machado, Léa Cristina Castellucci

Braz J Infect Dis. 2015 Mar-Apr; 19(2): 206–208. Published online 2015 Jan 27. doi: 10.1016/j.bjid.2014.12.008

PMCID:: PMC9425388

Article PDF–388K

Select item 934459118.

The Effect of HER2 Status on Metaplastic Breast Cancer A Propensity Score-Matched Analysis

Jin Hu, Yanting Zhang, Fang Dong, Jian Shen, Hengyu Chen, Lei Li, Tao Huang

Front Endocrinol (Lausanne) 2022; 13: 874815. Published online 2022 Jun 16. doi: 10.3389/fendo.2022.874815

PMCID:: PMC9344591

Article PDF–1.8M

Select item 933427219.

HER2-low breast cancer shows a lower immune response compared to HER2-negative cases

Nadine S. van den Ende, Marcel Smid, Annemieke Timmermans, Johannes B. van Brakel, Tim Hansum, Renée Foekens, Anita M. A. C. Trapman, Bernadette A. M. Heemskerk-Gerritsen, Agnes Jager, John W. M. Martens, Carolien H. M. van Deurzen

Sci Rep. 2022; 12: 12974. Published online 2022 Jul 28. doi: 10.1038/s41598-022-16898-6

PMCID:: PMC9334272

Article PDF–1.3M

Select item 932596520.

Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors

Hao Wang, Ji Miao, Yazhou Wen, Xihua Xia, Yanan Chen, Mengli Huang, Shiqing Chen, Zhengyi Zhao, Yuzi Zhang, Chunzhu Chen, Xinhua Zhu

Pathol Oncol Res. 2022; 28: 1610360. Published online 2022 Jul 13. doi: 10.3389/pore.2022.1610360

PMCID:: PMC9325965

Article PDF–2.4M

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Gene

Items: 1 to 20 of 1346

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity